Onderneming Arch Therapeutics, Inc. Other OTC
Aandelen
ARTH
US03939W1099
Medische apparatuur, benodigdheden & distributie
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Biotechnology
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +383,80% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +383,80% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Terrence Norchi
CEO | Chief Executive Officer | 59 | 16-09-09 |
Michael Abrams
DFI | Director of Finance/CFO | 55 | 10-05-21 |
Shawn Carlson
SAM | Sales & Marketing | - | 01-01-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Terrence Norchi
CEO | Chief Executive Officer | 59 | 16-09-09 |
Fish Guy
BRD | Director/Board Member | 64 | 31-12-21 |
Laurence Hicks
BRD | Director/Board Member | - | 27-09-21 |
Punit Dhillon
BRD | Director/Board Member | 44 | 01-07-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 4 444 363 | 3 988 423 ( 89,74 %) | 0 | 89,74 % |
Bedrijfsgegevens
![Adres Arch Therapeutics, Inc.(ARTH)](https://cdn.zonebourse.com/static/address/28376861.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+13,39% | 129 mld. | |
-9,21% | 10,82 mld. | |
-16,57% | 7,12 mld. | |
+41,54% | 5,66 mld. | |
-31,48% | 4,14 mld. | |
+8,95% | 3,46 mld. | |
-19,67% | 2,47 mld. | |
-16,74% | 1,95 mld. | |
-23,55% | 1,7 mld. |